我們已在上線！進一步了解

Hologic

HOLX

市值 US$170億

已下市

HOLX已於2026年4月6日下市。

返回排名列表

關於： Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

員工： 7,070

醫療保健醫療器材與用品

新聞

正面

中性

負面

市場情緒 3個月

正面 0%

中性 0%

負面 0%

Blackstone and TPG Complete Acquisition of Hologic

MARLBOROUGH, Mass. & NEW YORK & SAN FRANCISCO & FORT WORTH, Texas--(BUSINESS WIRE)---- $HOLX #holx--Blackstone and TPG Complete Acquisition of Hologic Accomplished MedTech leader Joe Almeida named Chief Executive Officer.

Blackstone and TPG Complete Acquisition of Hologic

Casey's General Stores Set to Join S&P 500; DigitalOcean Holdings to Join S&P MidCap 400; Broadstone Net Lease to Join S&P SmallCap 600

NEW YORK, April 6, 2026 /PRNewswire/ -- S&P MidCap 400 constituent Casey's General Stores Inc. (NASD: CASY) will replace Hologic Inc. (NASD: HOLX) in the S&P 500, S&P SmallCap 600 constituent DigitalOcean Holdings Inc. (NYSE: DOCN) will replace Casey's General Stores in the S&P MidCap 400, and Broadstone Net Lease Inc. (NYSE: BNL) will replace DigitalOcean Holdings in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, April 9. Affiliates of Blackstone Inc. and TPG Global are acquiring Hologic in a deal expected to be completed on or about April 7.

Casey's General Stores Set to Join S&P 500; DigitalOcean Holdings to Join S&P MidCap 400; Broadstone Net Lease to Join S&P SmallCap 600

Hologic Chief Executive Officer Steve MacMillan to Retire Upon Close of Go-Private Transaction

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #holx--Hologic Chief Executive Officer Steve MacMillan to Retire Upon Close of Blackstone/TPG Acquisition.

Hologic Chief Executive Officer Steve MacMillan to Retire Upon Close of Go-Private Transaction

Zacks Investment Research

Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It

Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It

Zacks Investment Research

HOLX vs. ALGN: Which MedTech Stock Is the Better Investment Pick Now?

Align Technology's growth surges on record aligner demand and DSO expansion, while Hologic's near-complete buyout leaves little upside for investors.

HOLX vs. ALGN: Which MedTech Stock Is the Better Investment Pick Now?

Zacks Investment Research

Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.

Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know

Zacks Investment Research

Hologic's Women's Health Index Flags Alarming Gaps in STI Screening

HOLX's Global Women's Health Index shows STI testing stagnates at 10%, leaving nearly 2 billion women at risk despite gains in other screenings.

Hologic's Women's Health Index Flags Alarming Gaps in STI Screening

Zacks Investment Research

Should You Hold or Sell HOLX Stock as It Nears the End of Public Phase?

Hologic nears its $76 buyout price as Diagnostics faces headwinds, tariffs hurt, and the stock trades at a sector premium.

Should You Hold or Sell HOLX Stock as It Nears the End of Public Phase?

1.5 Billion Women Miss Essential Preventive Tests, Despite Uptick in Global Screening Rates

WASHINGTON--(BUSINESS WIRE)---- $HOLX #gallup--1.5 Billion Women Miss Essential Preventive Tests, Despite Uptick in Global Screening Rates.

1.5 Billion Women Miss Essential Preventive Tests, Despite Uptick in Global Screening Rates

Zacks Investment Research

What Drives Hologic's GYN Surgical Strength in a Competitive Market?

HOLX expands its GYN Surgical reach with MyoSure, NovaSure and Gynesonics boost as the global women's health devices market grows and minimally invasive demand rises.

What Drives Hologic's GYN Surgical Strength in a Competitive Market?

查看新聞排名

價格圖表採用Lightweight Charts™實作